Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) to Initiate Phase 3 Trial Evaluating Epidiolex in Infantile Spasms (IS) in Q4 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 17, 2017
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT02954887?term=INFANTILE+SPASMS&rank=16
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Epidiolex, Infantile Spasms, Trial Initiation, Phase 3
